1,097
Views
11
CrossRef citations to date
0
Altmetric
Laboratory Study

Tacrolimus restores podocyte injury and stabilizes the expression of Cabin1 in 5/6 nephrectomized rats

, , , , , & show all
Pages 564-570 | Received 04 Nov 2015, Accepted 23 Jan 2016, Published online: 24 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yueqiang Wen, Jieru Chen, Lingling Liu, Guanhua Guo, Yinsi Zeng, Yujing Zhang, Zhili Zeng, Zebin Wang, Xuan Peng & Jianbo Liang. (2020) Cabin1 involves in renal tubular epithelial cells mitochondrial dysfunction through SIRT1/p53 pathway. Journal of Receptors and Signal Transduction 40:2, pages 141-147.
Read now
Lin Yan, Lin Jiaqiong, Guo Yue, Li Xiaoyong, Tan Xuexian, Long Ming, Li Yinglan, Liao Xinxue & Huang Zena. (2020) Atorvastatin protects against contrast-induced acute kidney injury via upregulation of endogenous hydrogen sulfide. Renal Failure 42:1, pages 270-281.
Read now

Articles from other publishers (9)

Marc Xipell, Gema M. Lledó, Allyson C. Egan, Farah Tamirou, Cristina Serrano del Castillo, Jordi Rovira, José A. Gómez-Puerta, Adriana García-Herrera, Ricard Cervera, Andreas Kronbichler, David R.W. Jayne, Hans-Joachim Anders, Frédéric Houssiau, Gerard Espinosa & Luis F. Quintana. (2023) From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies. Autoimmunity Reviews 22:10, pages 103404.
Crossref
Lijuan Zhao, Yanyan Yang, Hao Xu, Wei Leng & Guoshuang Xu. (2023) Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy. Frontiers in Pharmacology 14.
Crossref
Xueqing Hu, Wenqian Zhou, Shun Wu, Rui Wang, Zhiyong Luan, Xin Geng, Na Xu, Zhaoyong Zhang, Zhenmin Ruan, Zenghui Wang, Furong Li, Chen Yu & Hongqi Ren. (2021) Tacrolimus alleviates LPS‐induced AKI by inhibiting TLR4/MyD88/NF‐κB signalling in mice. Journal of Cellular and Molecular Medicine 26:2, pages 507-514.
Crossref
Huiwu Zhang, Xiuli Li, Haiping Xu, Fang Ran & Guoxia Zhao. (2021) Effect and safety evaluation of tacrolimus and tripterygium glycosides combined therapy in treatment of Henoch–Schönlein purpura nephritis. International Journal of Urology 28:11, pages 1157-1163.
Crossref
Ling Li, Min Zhu, De-Yi Li, Hong-Li Guo, Ya-Hui Hu, Ze-Yue Xu, Xia Jing, Feng Chen, Fei Zhao, Yun-Man Li, Jing Xu & Zheng Jiao. (2021) Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome. International Immunopharmacology 98, pages 107827.
Crossref
Guo-Xiang Hao, Xin Huang, Dong-Feng Zhang, Yi Zheng, Hai-Yan Shi, Yan Li, Evelyne Jacqz-Aigrain & Wei Zhao. (2018) Population pharmacokinetics of tacrolimus in children with nephrotic syndrome. British Journal of Clinical Pharmacology 84:8, pages 1748-1756.
Crossref
Yueqiang Wen, Lingling Liu, Qingdong Xu, Peilan Zhou, Huiyuan Li, Zebin Wang & Jianbo Liang. (2018) Knocking down Cabin1 induces glomerular podocyte injury. International Urology and Nephrology 50:5, pages 983-991.
Crossref
Yuan Yang, Li Zhao, Li Xiao, Yumei Liang, Chang Wang, Xiao Fu, Xuejing Zhu, Shuguang Yuan, Jianling Zhu, Xiaoping Zhu, Yinghong Liu, Jun Li, Jian Luo, Fuyou Liu & Lin Sun. (2018) Chlormethine Hydrochloride is Not Inferior to Tacrolimus in Treating Steroid-Resistant Nephrotic Syndrome. Kidney and Blood Pressure Research 43:1, pages 68-79.
Crossref
Mi-yeon Yu, Yong-Chul Kim, Ho Suk Koo & Ho Jun Chin. (2017) Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study. PLOS ONE 12:11, pages e0188375.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.